The laboratory
The LMDM, established in 2001, applies computational methods to the investigation of biological problems, focusing on the structural modelling of molecular complexes and biomembranes by Classical and Quantum Mechanics, followed by Molecular Dynamics simulations. In quantum modelling, the group investigates the role of intermolecular electron density in binding free energy, molecular recognition and signalling.
We develop automated methods for prospecting biological targets and their potential modulators, applicable at the proteome scale; among them, tools for generating homo-oligomers and molecular docking strategies.
In computer-aided drug development, recent work has concentrated on targets of neglected diseases, which affect low-income and vulnerable populations and receive little investment. The systems investigated include the CoaBC enzyme of Mycobacterium tuberculosis, falcipains of Plasmodium falciparum, cruzain of Trypanosoma cruzi and nucleoside hydrolase of Leishmania donovani. We have also identified non-competitive inhibitors at previously undescribed allosteric binding sites in enzymes.